PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Microwave tumor ablation continues to evolve into a viable treatment option for many cancers. Current systems are
poised to supplant radiofrequency ablation as the dominant percutaneous thermal therapy. Here is provided an overview
of technical details and early clinical results with a high-powered, gas-cooled microwave ablation system.
The system was developed with academic-industry collaboration using federal and private funding. The generator
comprises three synchronous channels that each produce up to 140W at 2.45GHz. A mountable power distribution
module facilitates CT imaging guidance and monitoring and reduces clutter in the sterile field. Cryogenic carbon-dioxide
cools the coaxial applicator, permitting a thin applicator profile (~1.5 mm diameter) and high power delivery.
A total of 106 liver tumors were treated (96 malignant, 10 benign) from December 2010 to June 2012 at a single
academic institution. Mean tumor size ± standard deviation was 2.5±1.3cm (range 0.5-13.9cm). Treatment time was
5.4±3.3min (range 1-20min). Median follow-up was 6 months (range 1-16 months). Technical success was reported in
100% of cases. Local tumor progression was noted in 4/96 (4.3%) of malignancies. The only major complication was a
pleural effusion that was treated with thoracentesis.
Microwave ablation with this system is an effective treatment for liver cancer. Compared to previous data from the same
institution, these results suggest an increased efficacy and equivalent safety to RF ablation. Additional data from the lung
and kidney support this conclusion.
Christopher L. Brace,Timothy J. Ziemlewicz,Rick Schefelker,J. Louis Hinshaw,Meghan G. Lubner, andFred T. Lee Jr.
"Microwave tumor ablation: cooperative academic-industry development of a high-power gas-cooled system with early clinical
results", Proc. SPIE 8584, Energy-based Treatment of Tissue and Assessment VII, 858405 (26 February 2013); https://doi.org/10.1117/12.2004094
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Christopher L. Brace, Timothy J. Ziemlewicz, Rick Schefelker, J. Louis Hinshaw, Meghan G. Lubner, Fred T. Lee Jr., "Microwave tumor ablation: cooperative academic-industry development of a high-power gas-cooled system with early clinical
results," Proc. SPIE 8584, Energy-based Treatment of Tissue and Assessment VII, 858405 (26 February 2013); https://doi.org/10.1117/12.2004094